Carla A. Harris - 14 Mar 2024 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Mar 2024
Net transactions value
+$360
Form type
4
Filing time
18 Mar 2024, 16:49:26 UTC
Previous filing
04 Jan 2024
Next filing
02 Apr 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $360 +5 +0.1% $71.90 5,006 14 Mar 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.

Remarks:

The reporting person's disclosure rounds deferred shares to the nearest whole number.